Primecap Management’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $24.5M | Buy |
|
|||||
|
2022
Q1 | $17.9M | Buy |
|
|||||
|
2021
Q4 | $38.4M | Buy |
|
|||||
|
2021
Q3 | $78.4M | Buy |
|
|||||
|
2021
Q2 | $127M | Buy |
|
|||||
|
2021
Q1 | $133M | Buy |
|
|||||
|
2020
Q4 | $165M | Buy |
|
|||||
|
2020
Q3 | $180M | Buy |
|
|||||
|
2020
Q2 | $242M | Buy |
|
|||||
|
2020
Q1 | $210M | Sell |
|
|||||
|
2019
Q4 | $336M | Buy |
|
|||||
|
2019
Q3 | $118M | Buy |
|
|||||
|
2019
Q2 | $129M | Buy |
|
|||||
|
2019
Q1 | $127M | Buy |
|
|||||
|
2018
Q4 | $58.9M | Sell |
|
|||||
|
2018
Q3 | $102M | Buy |
|
|||||
|
2018
Q2 | $131M | Buy |
|
|||||
|
2018
Q1 | $147M | Sell |
|
|||||
|
2017
Q4 | $104M | Buy |
|
|||||
|
2017
Q3 | $157M | Buy |
|
|||||
|
2017
Q2 | $98.7M | Sell |
|
|||||
|
2017
Q1 | $112M | Sell |
|
|||||
|
2016
Q4 | $79.2M | Buy |
|
|||||
|
2016
Q3 | $64.2M | Buy |
|
|||||
|
2016
Q2 | $66.7M | Sell |
|
|||||
|
2016
Q1 | $79M | Buy |
|
|||||
|
2015
Q4 | $84M | Sell |
|
|||||
|
2015
Q3 | $77.7M | Buy |
|
|||||
|
2015
Q2 | $145M | Hold |
|
|||||
|
2015
Q1 | $113M | Buy |
|
|||||
|
2014
Q4 | $77.6M | Buy |
|
|||||
|
2014
Q3 | $38.5M | Buy |
|
|||||
|
2014
Q2 | $36.9M | Buy |
|
|||||
|
2014
Q1 | $27M | Buy |
|
|||||
|
2013
Q4 | $5M | Hold |
|
|||||
|
2013
Q3 | $9.62M | Hold |
|
|||||
|
2013
Q2 | $6.76M | Buy |
|